87 related articles for article (PubMed ID: 6380041)
1. Cellular immunoabsorption using monoclonal antibodies. Selective removal of T cells from peripheral blood and bone marrow.
Berenson RJ; Levitt LJ; Levy R; Miller RA
Transplantation; 1984 Aug; 38(2):136-42. PubMed ID: 6380041
[TBL] [Abstract][Full Text] [Related]
2. T lymphocyte depletion of human peripheral blood and bone marrow using monoclonal antibodies and magnetic microspheres.
Gee AP; Lee C; Sleasman JW; Madden M; Ugelstad J; Barrett DJ
Bone Marrow Transplant; 1987 Aug; 2(2):155-63. PubMed ID: 2901878
[TBL] [Abstract][Full Text] [Related]
3. Purging of T-lymphocytes with magnetic affinity colloid.
Yau JC; Reading CL; Thomas MW; Davaraj BM; Tindle SE; Jagannath S; Dicke KA
Exp Hematol; 1990 Mar; 18(3):219-22. PubMed ID: 2303117
[TBL] [Abstract][Full Text] [Related]
4. Effects of CD34+ selection and T cell immunodepletion on cord blood hematopoietic progenitors: relevance to stem cell transplantation.
Laver J; Traycoff CM; Abdel-Mageed A; Gee A; Lee C; Turner C; Srour EF; Abboud M
Exp Hematol; 1995 Dec; 23(14):1492-6. PubMed ID: 8542936
[TBL] [Abstract][Full Text] [Related]
5. Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies.
Vartdal F; Kvalheim G; Lea TE; Bosnes V; Gaudernack G; Ugelstad J; Albrechtsen D
Transplantation; 1987 Mar; 43(3):366-71. PubMed ID: 3103274
[TBL] [Abstract][Full Text] [Related]
6. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
[TBL] [Abstract][Full Text] [Related]
7. The role of accessory cells in allogeneic peripheral blood stem cell transplantation.
Tanaka J; Imamura M; Kasai M; Asaka M; Torok-Storb B
Int J Hematol; 1999 Feb; 69(2):70-4. PubMed ID: 10071453
[TBL] [Abstract][Full Text] [Related]
8. Selective T cell subset depletion with anti-CD4 and anti-CD8 intact ricin immunotoxins.
Izquierdo M; Balboa MA; Figuera A; López-Botet M
Clin Exp Immunol; 1988 Nov; 74(2):300-4. PubMed ID: 3265657
[TBL] [Abstract][Full Text] [Related]
9. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
10. Immunotoxin depletion of T cells and its effect on hematopoietic progenitor cells in human cord blood.
Xu M; Lu S; Shen B; Li Y
Chin Med J (Engl); 2001 Apr; 114(4):355-9. PubMed ID: 11780453
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two immuno-mechanical methods of T-cell depletion of human bone-marrow for prevention of graft-versus-host disease: soybean lectin agglutination and sheep erythrocyte rosette depletion versus triple rosette depletion.
Woolfrey AE; Neudorf S; Filipovich AH
Thymus; 1985; 7(6):327-34. PubMed ID: 3909540
[TBL] [Abstract][Full Text] [Related]
12. Removal of T cells from bone marrow for transplantation. Comparison of rat monoclonal anti-lymphocyte antibodies of different isotypes.
Hale G; Hoang T; Prospero T; Watt SM; Waldmann H
Mol Biol Med; 1983 Oct; 1(3):305-19. PubMed ID: 6390085
[TBL] [Abstract][Full Text] [Related]
13. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Leblanc P; Symann ML
Cancer Res; 1994 Jul; 54(14):3800-7. PubMed ID: 7913409
[TBL] [Abstract][Full Text] [Related]
14. Quantity and nature of residual bone marrow T cells after treatment of the marrow with Campath-1.
Irlé C; Kaestli M; Aapro M; Chapuis B; Jeannet M
Exp Hematol; 1987 Feb; 15(2):163-70. PubMed ID: 3545877
[TBL] [Abstract][Full Text] [Related]
15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
[TBL] [Abstract][Full Text] [Related]
17. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
18. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
19. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
Jun HX; Jun CY; Yu ZX
Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
[TBL] [Abstract][Full Text] [Related]
20. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]